NTx’s new services offering provides faster and more affordable high-integrity, complex mRNA production powered by NTxscribe® ...
Hosted on MSN16d
Primrose Bio and ExPLoRNA Therapeutics link for mRNA therapiesExPLoRNA Therapeutics specialises in mRNA innovations, focusing on new cap analogues that are crucial for successful protein ...
The Food and Drug Administration approved an updated coronavirus vaccine manufactured by Novavax Friday, days after new mRNA coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna ...
LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...
Primrose Bio, a leading biotechnology company specializing in technologies that improve the manufacturing of next-generation ...
Milestone marks a significant step toward producing mRNA vaccines in Canada by 2025 CAMBRIDGE, MA / ACCESSWIRE / September 9, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that its ...
NTx Services offers faster turnaround, more flexibility, and scalability than traditional mRNA production processes by leveraging the NTxscribe continuous flow in vitro transcription (IVT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback